An MS Drug Takes a Feisty Approach Aimed at Younger Patients
The Swiss drug maker Novartis is taking a sassy new tack to win converts to its oral multiple sclerosis treatment, Gilenya. Its “Hey MS, Take This!” campaign shows patients sticking out their tongues with Gilenya capsules on them to show their willingness to fight back against the neurological condition..... Read More - http://www.ms-uk.org/index.cfm/MSnews
MS Drug Takes a Feisty Approach Aimed at Younger Patients
MS Drug Takes a Feisty Approach Aimed at Younger Patients
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1413 Views
-
Last post by Jaded
-
- 0 Replies
- 1619 Views
-
Last post by frodo
-
- 0 Replies
- 1611 Views
-
Last post by NHE
-
- 0 Replies
- 1729 Views
-
Last post by NHE
-
- 0 Replies
- 672 Views
-
Last post by NHE
-
- 1 Replies
- 3361 Views
-
Last post by Tif
-
- 0 Replies
- 2604 Views
-
Last post by frodo
-
- 0 Replies
- 310 Views
-
Last post by DIM
-
- 2 Replies
- 1241 Views
-
Last post by DIM